Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
AIM ImmunoTech Inc. (AIM) had Operating Cash Flow per Share of $-4.29 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.03M |
|
$-3.28M |
|
$0.07M |
|
$-0.04M |
|
$2.47M |
|
$-2.45M |
|
$-0.84M |
|
$-3.28M |
|
$-3.28M |
|
$-3.28M |
|
$-3.28M |
|
$-3.28M |
|
$-3.28M |
|
$-2.45M |
|
$-2.24M |
|
2.09M |
|
2.09M |
|
$-1.57 |
|
$-1.57 |
|
| Balance Sheet Financials | |
$2.58M |
|
$0.08M |
|
$2.92M |
|
$5.49M |
|
$4.04M |
|
-- |
|
$7.53M |
|
$11.57M |
|
$-6.08M |
|
$-8.12M |
|
$-6.08M |
|
2.76M |
|
| Cash Flow Statement Financials | |
$-8.97M |
|
$1.95M |
|
$7.67M |
|
$1.70M |
|
$2.35M |
|
$0.65M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-- |
|
-0.31 |
|
-161.54% |
|
-9411.54% |
|
-9411.54% |
|
-- |
|
-12630.77% |
|
-12630.77% |
|
$-8.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
54.04% |
|
40.45% |
|
-59.77% |
|
54.04% |
|
$-2.20 |
|
$-4.29 |
|
|
Operating Cash Flow per Share |
$-4.29 |